Nachrichten vom 07.11.18

22:05		Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
22:05		American Hotel Income Properties REIT LP Reports Third Quarter 2018 Results
22:05		Grubhub Completes Acquisition of Tapingo
22:05		Dehydrated Vegetables Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028
22:05		Blockchain for the Connected Home and Entertainment
22:05		Cumberland Pharmaceuticals To Announce Third Quarter 2018 Financial Results
22:05		Revance to Participate in the Credit Suisse Healthcare Conference
22:05		Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Fitbit, Inc. - FIT
22:05		QuickLogic Reports Fiscal 2018 Third Quarter Results
22:05		Adams Resources & Energy, Inc. Announces Results For Third Quarter 2018 And Declares Quarterly Dividend
22:05		AgroFresh Solutions Reports Results for Third Quarter and First Nine Months of 2018
22:05		At Home Group Inc. Announces Proposed Refinancing of Term Loan Facility
22:05		Xcel Energy Announces a $400MM Public Offering of Common Stock with a Forward Component
22:05		Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences
22:05		Curis to Present at 33rd Society for Immunotherapy of Cancer Annual Meeting and Cowen IO NEXT Summit
22:05		AI, Machine Learning, and Data Analytics in the Smart Home
22:05		Digital Transaction Management Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028
22:05		REGENXBIO Reports Third Quarter 2018 Financial and Operating Results and Announces Initiation of Phase I/II Clinical Trial for RGX-121 for the Treatment of MPS II
22:05		Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018
22:05		Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
22:05		Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress
22:05		Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences
22:05		FitMetrix Revolutionizes Group Fitness With Visual Workout Builder Technology
22:05		Thermo Fisher Scientific Elects New Director to Board
22:05		Alexandria Real Estate Equities, Inc. Announces Development of New Build-to-Suit at the Alexandria Life Science and Translational Research Center at 9800 Medical Center Drive with Signing of 15-Ye...
22:05		Hill-Rom Declares Fiscal 2019 First Quarter Dividend
22:05		Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
22:05		Novavax Reports Third Quarter 2018 Financial Results
22:05		Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights
22:05		American Hotel Income Properties REIT LP Reports Third Quarter 2018 Results
22:03		EARNINGS SUMMARY: Details of REALNETWORKS INC Q3 Earnings Report
22:03		Roku Releases Third Quarter 2018 Financial Results
22:02		Qualcomm Earnings Release Available on Company's Investor Relations Website
22:01		DaVita Inc. 3rd Quarter 2018 Results
22:01		MGE Energy Issues Third-Quarter Financial Update
22:01		Craft Brew Alliance Announces Accelerated 9% Depletions Growth for Kona in the Third Quarter and Highlights Successful Expansion of Portfolio with Acquisition of Three Regional Craft Brands
22:01		Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results
22:01		Hawaiian Airlines Reports October 2018 Traffic Statistics
22:01		RealNetworks Announces Third Quarter 2018 Results
22:01		Trex Brings Affordability and Ease to the Outdoors with New Decking and Railing Offerings
22:01		Magyar Bancorp, Inc. Announces Fourth Quarter And Year End Financial Results
22:01		SPENGA-New Fitness Studio In Chandler Offers Unrivaled Fitness Experience
22:01		Pareteum Announces Record Third Quarter 2018 Results
22:01		Upland Software to Present at the Raymond James Technology Investors Conference
22:01		DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update
22:01		Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference
22:01		Tocagen to Participate in Investor Conferences in November
22:01		Kindred Biosciences Announces Third Quarter 2018 Financial Results
22:01		Vanda Pharmaceuticals Reports Third Quarter 2018 Financial Results
22:01		Red Rock Resorts Announces Third Quarter 2018 Results

Erste Seite Zurück | ... | 4 | 5 | 6 | 7 | Weiter

Archiv

November 2018

Mo	Di	Mi	Do	Fr	Sa	So
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30

Oktober 2018

Mo	Di	Mi	Do	Fr	Sa	So
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

September 2018

Mo	Di	Mi	Do	Fr	Sa	So
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

August 2018

Mo	Di	Mi	Do	Fr	Sa	So
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Juli 2018

Mo	Di	Mi	Do	Fr	Sa	So
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Juni 2018

Mo	Di	Mi	Do	Fr	Sa	So
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30

Mai 2018

Mo	Di	Mi	Do	Fr	Sa	So
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds